News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Melissa Fassbender
- Last updated on
In his new role as VP of information technology at Paragon, McCaul told us he is looking forward to partnering with the Paragon team and clients “to speed these treatments to patients with a solid IT foundation for compliance and efficiency, and innovative process data visibility and analytics.”
“We are in an exciting area of growth for the industry, and Paragon is in a great position to accelerate drug development and commercialization for cutting edge treatments,” he said.
According to the company, McCaul's technical and business expertise will help it move to a scalable, multi-site platform to accommodate growth.
McCaul held several position at Merck, culminating his career at the company as the director of global IT research for preclinical small molecule development.
Paragon has also recently appointed Philip Wills, PhD, as chief commercial officer, John Conner as chief manufacturing officer, and William Thomas, Jr., PhD, as chief scientific officer.